New hope for transplant patients with advanced skin cancer: experimental virus therapy tested
NCT ID NCT04349436
First seen Nov 01, 2025 · Last updated Apr 26, 2026 · Updated 23 times
Summary
This study tests an experimental drug called RP1, which is injected directly into skin tumors, for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink or control the cancer while being safe for the transplanted organ. About 69 participants will receive treatment every two weeks for up to two years, with follow-up for up to three years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Duke University
Durham, North Carolina, 27708, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Medical Dermatology Specialists
Phoenix, Arizona, 85006, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Rochester Dermatologic Surgery
New York, New York, 14564, United States
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
UCSF, Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94143, United States
-
University of California, Los Angeles
Los Angeles, California, 90024, United States
-
University of California, San Diego
La Jolla, California, 92093, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Colorado Cancer Center School of Medicine
Aurora, Colorado, 80045, United States
-
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
University of Tennessee Medical Center at Knoxville
Knoxville, Tennessee, 37920, United States
-
University of Texas Southwestern
Dallas, Texas, 75235, United States
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.